2017
Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684–1692
Inzucchi SE, Viscoli CM, Young LH, Furie KL, Gorman M, Lovejoy AM, Dagogo-Jack S, Ismail-Beigi F, Korytkowski MT, Pratley RE, Schwartz GG, Kernan WN. Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684–1692. Diabetes Care 2017, 40: e47-e48. PMID: 28325804, PMCID: PMC5360290, DOI: 10.2337/dci16-0048.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsCerebrovascular DisordersDiabetes Mellitus, Type 2HumansHyperglycemiaHypoglycemic AgentsInsulinInsulin ResistancePioglitazoneThiazolidinediones
1991
A prognostic system for transient ischemia or minor stroke.
Kernan WN, Horwitz RI, Brass LM, Viscoli CM, Taylor KJ. A prognostic system for transient ischemia or minor stroke. Annals Of Internal Medicine 1991, 114: 552-7. PMID: 2001088, DOI: 10.7326/0003-4819-114-7-552.Peer-Reviewed Original ResearchMeSH KeywordsAgedCarotid ArteriesCerebrovascular DisordersCohort StudiesFemaleHumansIschemic Attack, TransientMaleMiddle AgedPrognosisRecurrenceRisk FactorsStatistics as TopicUltrasonographyConceptsCarotid transient ischemic attacksTransient ischemic attackMinor strokeOutcome ratesRisk group 1Ischemic attackTransient ischemiaPrognostic systemGroup 1Urban community teaching hospitalInception cohort studyCommunity teaching hospitalEligible patientsCohort studyClinical featuresOriginal cohortTeaching hospitalTest cohortStrokePatientsSubsequent strokeHypertensionIschemiaDeathDiabetes